• Nenhum resultado encontrado

Thyroid Dysfunction in Hepatitis C Individuals Treated With Interferon-Alpha and Ribavirin - A Review

N/A
N/A
Protected

Academic year: 2019

Share "Thyroid Dysfunction in Hepatitis C Individuals Treated With Interferon-Alpha and Ribavirin - A Review"

Copied!
5
0
0

Texto

Loading

Referências

Documentos relacionados

current treatment for hepatitis C is administration of in- terferon alpha (IFN- α ) or its most recent form, pegylated interferon (Peg-IFN), combined with ribavirin and the du-

Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature. Chung YH,

The association between viral load, and SVR with the development of thyroid disorders was not part of this study protocol, considering that our prima- ry objective was the

• § 3o Os órgãos e entidades integrantes da administração pública federal atuantes em pesquisa, desenvolvimento ou capacitação tecnológica terão por meta efetivar

Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation.. Bruno S, Shiffman ML, Roberts SK,

CHRONIC HEPATITIS C VIRUS INFECTIONS IN BRAZILIAN PATIENTS: ASSOCIATION WITH GENOTYPES, CLINICAL PARAMETERS AND RESPONSE TO LONG TERM ALPHA

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin

The role autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon alpha and ribavirin combination